The mission continues. Let science be the guide.
Congress questions FDA on plans to catch up and move forward with facility inspections as pandemic travel restrictions ease.
Vaccines define the path to putting pandemic restrictions and pain in the rear-view mirror.
Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates.
As face masks start to come off, bio/pharma’s COVID-19 battle goes on.
Smart, accurate, science-based messaging is needed to advance bio/pharma science.
Bio/pharma works hard today to change the calendar to tomorrow.
A complicated vaccination rollout and mixed messages may derail the pandemic endgame
Demand for specific advanced laboratory skills creates a positive employment market.
After a hectic 2020, biopharma looks to deliver on COVID-19 vaccines and move other promising therapies forward.